HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A prospective study of brachytelephalangic chondrodysplasia punctata: identification of arylsulfatase E mutations, functional analysis of novel missense alleles, and determination of potential phenocopies.

AbstractPURPOSE:
The only known genetic cause of brachytelephalangic chondrodysplasia punctata is X-linked chondrodysplasia punctata 1 (CDPX1), which results from a deficiency of arylsulfatase E (ARSE). Historically, ARSE mutations have been identified in only 50% of male patients, and it was proposed that the remainder might represent phenocopies due to maternal-fetal vitamin K deficiency and maternal autoimmune diseases.
METHODS:
To further evaluate causes of brachytelephalangic chondrodysplasia punctata, we established a Collaboration Education and Test Translation program for CDPX1 from 2008 to 2010. Of the 29 male probands identified, 17 had ARSE mutations that included 10 novel missense alleles and one single-codon deletion. To determine pathogenicity of these and additional missense alleles, we transiently expressed them in COS cells and measured arylsulfatase E activity using the artificial substrate, 4-methylumbelliferyl sulfate. In addition, clinical data were collected to investigate maternal effects and genotype-phenotype correlations.
RESULTS:
In this study, 58% of males had ARSE mutations. All mutant alleles had negligible arylsulfatase E activity. There were no obvious genotype-phenotype correlations. Maternal etiologies were not reported in most patients.
CONCLUSION:
CDPX1 is caused by loss of arylsulfatase E activity. Around 40% of male patients with brachytelephalangic chondrodysplasia punctata do not have detectable ARSE mutations or known maternal etiological factors. Improved understanding of arylsulfatase E function is predicted to illuminate other etiologies for brachytelephalangic chondrodysplasia punctata.
AuthorsClaudia Matos-Miranda, Graeme Nimmo, Bradley Williams, Carolyn Tysoe, Martina Owens, Sherri Bale, Nancy Braverman
JournalGenetics in medicine : official journal of the American College of Medical Genetics (Genet Med) Vol. 15 Issue 8 Pg. 650-7 (Aug 2013) ISSN: 1530-0366 [Electronic] United States
PMID23470839 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • ARSL protein, human
  • Arylsulfatases
Topics
  • Alleles
  • Animals
  • Arylsulfatases (chemistry, genetics, metabolism)
  • COS Cells
  • Chlorocebus aethiops
  • Chondrodysplasia Punctata (etiology, genetics, pathology)
  • DNA Mutational Analysis
  • Genetic Diseases, X-Linked (etiology, genetics, pathology)
  • Genetic Variation
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Mutation, Missense
  • Phenotype
  • Prospective Studies
  • Quantitative Trait, Heritable

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: